The three major stock indexes were mostly lower on Monday as peace talks between the U.S. and Iran faltered and global Brent ...

Talk about a missed opportunity: the first competitive marathon runner to complete the race in under two hours wore Adidas ...

Terns Pharmaceuticals said it received a breakthrough therapy designation from U.S. regulators for its leukemia treatment. The Food and Drug Administration granted the designation to TERN-701, which ...

Humana's CenterWell Pharmacy said it has expanded its partnership with Mark Cuban Cost Plus Drug Company to develop employer-focused prescription-drug solutions.

An uneven rally is just one reason why the Goldman Sachs trading desk is bracing for a pullback after the S&P 500's ninth ...

Akita Drilling agreed to acquire all of Paramount Resources' interests in Fox Drilling, a privately-held contractor that runs a fleet of drilling rigs operating in Western Canada. Akita, a operator of ...

Oruka Therapeutics shares gained after the company announced positive results for its Phase 2a trial of a psoriasis treatment. The stock jumped 22% to $84 in premarket trading Monday. Through Friday's ...

Compass Therapeutics said its cancer treatment improved progression-free survival in a recent trial, but didn't meet its secondary endpoint in overall survival. Shares fell 23% to $3.85 in premarket ...

NervGen Pharma has hired Keith Vendola as the clinical-stage biopharmaceutical company's new chief financial officer. NervGen on Monday said Vendola joins from Wugen, where he had been finance chief ...

Critical Metals said it plans to acquire European Lithium in an all-stock deal valued at about $835 million, a move that would give it full ownership of a rare-earths project in Greenland and unwind a ...

A safer and more effective formulation of the most popular hair-loss treatment led to robust hair growth in a clinical trial.

She got a check in the mail for a class-action settlement and cashed it. It later bounced and now they are deducting that ...